Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract CancersRachna T. Shroff, Mitesh J. Borad, Milind Javle et al.|JAMA Oncology|2019Cited by 472
Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trialAhmed O. Kaseb, Padmanee Sharma, Sonali Jindal et al.|The Lancet. Gastroenterology & hepatology|2022Cited by 255
Obesity Early in Adulthood Increases Risk but Does Not Affect Outcomes of Hepatocellular CarcinomaManal M. Hassan, Donghui Li, Reham Abdel‐Wahab et al.|Gastroenterology|2015Cited by 107
Hepatocellular carcinoma recurrence after treatment with direct-acting antivirals: First, do no harm by withdrawing treatmentHarrys A. Torres, Ahmed O. Kaseb, Jean‐Nicolas Vauthey et al.|Journal of Hepatology|2016Cited by 79
Molecular Profiling of Hepatocellular Carcinoma Using Circulating Cell-Free DNAAhmed O. Kaseb, Razelle Kurzrock, Nora Sánchez et al.|Clinical Cancer Research|2019Cited by 76